Epigenetic scars of CD8+ T cell exhaustion persist after cure of chronic infection in humans

Nat Immunol. 2021 Aug;22(8):1020-1029. doi: 10.1038/s41590-021-00979-1. Epub 2021 Jul 26.

Abstract

T cell exhaustion is an induced state of dysfunction that arises in response to chronic infection and cancer. Exhausted CD8+ T cells acquire a distinct epigenetic state, but it is not known whether that chromatin landscape is fixed or plastic following the resolution of a chronic infection. Here we show that the epigenetic state of exhaustion is largely irreversible, even after curative therapy. Analysis of chromatin accessibility in HCV- and HIV-specific responses identifies a core epigenetic program of exhaustion in CD8+ T cells, which undergoes only limited remodeling before and after resolution of infection. Moreover, canonical features of exhaustion, including super-enhancers near the genes TOX and HIF1A, remain 'epigenetically scarred.' T cell exhaustion is therefore a conserved epigenetic state that becomes fixed and persists independent of chronic antigen stimulation and inflammation. Therapeutic efforts to reverse T cell exhaustion may require new approaches that increase the epigenetic plasticity of exhausted T cells.

Publication types

  • Clinical Trial, Phase III
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2-Naphthylamine / therapeutic use
  • Anilides / therapeutic use
  • Antigens, Viral / immunology*
  • Antiviral Agents / therapeutic use
  • CD8-Positive T-Lymphocytes / immunology*
  • CD8-Positive T-Lymphocytes / pathology*
  • Chromatin / metabolism
  • Cyclopropanes / therapeutic use
  • Epigenesis, Genetic / genetics
  • Hepacivirus / drug effects
  • Hepacivirus / immunology*
  • Hepatitis C, Chronic / drug therapy
  • Hepatitis C, Chronic / immunology*
  • High Mobility Group Proteins / genetics
  • Humans
  • Hypoxia-Inducible Factor 1, alpha Subunit / genetics
  • Immunologic Memory / immunology*
  • Lactams, Macrocyclic / therapeutic use
  • Proline / analogs & derivatives
  • Proline / therapeutic use
  • Ribavirin / therapeutic use
  • Ritonavir / therapeutic use
  • Sulfonamides / therapeutic use
  • Uracil / analogs & derivatives
  • Uracil / therapeutic use
  • Valine / therapeutic use

Substances

  • Anilides
  • Antigens, Viral
  • Antiviral Agents
  • Chromatin
  • Cyclopropanes
  • HIF1A protein, human
  • High Mobility Group Proteins
  • Hypoxia-Inducible Factor 1, alpha Subunit
  • Lactams, Macrocyclic
  • Sulfonamides
  • TOX protein, human
  • ombitasvir
  • Ribavirin
  • Uracil
  • Proline
  • 2-Naphthylamine
  • dasabuvir
  • Valine
  • Ritonavir
  • paritaprevir